William Blair Upgrades Amgen (AMGN) to Outperform
More News related to AMGN
- New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
- Amgen Highlights Data to be Presented at ASH
- Beacon Equity Issues Technical Trading Overview for NexMed Inc.
- Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
- Amgen to Present at Lazard Capital Healthcare Conference
More News related to Upgrades
- Knight (KNX), USA Truck (USAK), Werner (WERN) Higher Amid Avondale Upgrades
- William Blair Upgrades Manpower (MAN) Amid Strong Jobs Report
- Pritchard Capital Upgrades Geokinetics (GOK) to Buy
- Argus Upgrades ADC Telecommunications (ADCT) to Buy
- Oppenheimer Upgrades Akamai Tech (AKAM) to Outperform
William Blair upgrades Amgen (Nasdaq: AMGN) from Market Perform to Outperform.
Amgen, Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology.
Related Categories
UpgradesStocks Mentioned
+0.30Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
